Latest Breaking News On - Key anticipated company - Page 1 : comparemela.com

Passage Bio Announces 2022 Research and Clinical Development Goals to Advance Robust CNS Pipeline - . | January 10, 2022

University of pennsylvaniaUnited statesGwen fisherStuart hendersonBruce goldsmithExchange commissionKey anticipated companyClinical development goals to advance robustUniversity of pennsylvania gene therapy programGene therapy program at pennPassage bio incPassage bio announcesClinical development goalsAdvance robustInvestigational new drugPrinceton west innovation campus